Author

Julio Cortijo

Observed names: CORTIJO, JULIO, Cortijo Gimeno, Julio, Cortijo, J, Cortijo, J., Cortijo, Julio, Cortijo,J, J Cortijo, J Cortijo-Gimeno, J Cortijo-Jimeno, J. Cortijo, J. Cortijo Gimeno, J. Cortijo-Gimeno, J.G. Cortijo, JULIO CORTIJO, Julio Cortijo Gimeno

Institutions: Universitat de València, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias

ORCID: 0000-0003-1724-4784

Observed ORCID: 0000-0003-1724-4784

OpenAlex ID: A5111464534

Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke

2013 · Javier Milara, Teresa Peiró, et al. · Thorax · 324

Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets

2019 · Beatriz Ballester, Javier Milara, et al. · International Journal of Molecular Sciences · 308

Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms

2021 · Paula Montero, Javier Milara, et al. · International Journal of Molecular Sciences · 254

Electrical and mechanical effects of BRL34915 in guinea‐pig isolated trachealis

1986 · S.L. Allen, J.P. Boyle, et al. · British Journal of Pharmacology · 204

The JAK2 pathway is activated in idiopathic pulmonary fibrosis

2018 · Javier Milara, Gracia Hernandez, et al. · Respiratory Research · 187

Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition

2011 · Javier Milara, Rafael Navarro, et al. · Thorax · 172

Menopause and Ovariectomy Cause a Low Grade of Systemic Inflammation that May Be Prevented by Chronic Treatment with Low Doses of Estrogen or Losartan

2009 · May Abu-Taha, Cristina Rius, et al. · The Journal of Immunology · 162

Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis

2022 · Cristina Estornut, Javier Milara, et al. · Frontiers in Pharmacology · 133

N-acetyl-l-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)

2011 · Manuel Mata, Esteban Morcillo, et al. · Biochemical Pharmacology · 131

Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile

2009 · Amadeu Gavaldà, Montserrat Miralpeix, et al. · Journal of Pharmacology and Experimental Therapeutics · 130

Angiotensin II Induces Neutrophil Accumulation In Vivo Through Generation and Release of CXC Chemokines

2004 · Yafa Naim Abu Nabah, Teresa Mateo, et al. · Circulation · 124

In vivo antioxidant treatment protects against bleomycin‐induced lung damage in rats

2003 · A Serrano‐Mollar, D Closa, et al. · British Journal of Pharmacology · 122

Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin‐induced lung injury

2009 · J Cortijo, A Iranzo, et al. · British Journal of Pharmacology · 114

Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus

1993 · J. Cortijo, J. Bou, et al. · British Journal of Pharmacology · 113

Mucus and MUC in asthma

2005 · Esteban J Morcillo, Julio Cortijo · Current Opinion in Pulmonary Medicine · 112

PDE4 inhibitors as new anti-inflammatory drugs: Effects on cell trafficking and cell adhesion molecules expression

2005 · María Jesús Sanz, Julio Cortijo, et al. · Pharmacology & Therapeutics · 108

Oxidative Stress and Pulmonary Inflammation: Pharmacological Intervention With Antioxidants

1999 · ESTEBAN J. MORCILLO, JOSE ESTRELA, et al. · Pharmacological Research · 108

Attenuation by oralN-acetylcysteine of bleomycin-induced lung injury in rats

2001 · J. Cortijo, M. Cerdá-Nicolás, et al. · European Respiratory Journal · 104

Angiotensin II-Induced Mononuclear Leukocyte Interactions with Arteriolar and Venular Endothelium Are Mediated by the Release of Different CC Chemokines

2006 · Teresa Mateo, Yafa Naim Abu Nabah, et al. · The Journal of Immunology · 98

Trans- but Not Cis-Resveratrol Impairs Angiotensin-II–Mediated Vascular Inflammation through Inhibition of NF-κB Activation and Peroxisome Proliferator-Activated Receptor-γ Upregulation

2010 · Cristina Rius, May Abu-Taha, et al. · The Journal of Immunology · 96

OralN‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats

2003 · M. Mata, A. Ruíz, et al. · European Respiratory Journal · 93

Respiratory Syncytial Virus Inhibits Ciliagenesis in Differentiated Normal Human Bronchial Epithelial Cells: Effectiveness of N-Acetylcysteine

2012 · Manuel Mata, Irene Sarrion, et al. · PLoS ONE · 87

Roflumilast N‐oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro

2012 · J Milara, M Armengot, et al. · British Journal of Pharmacology · 86

JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study

2018 · Javier Milara, Beatriz Ballester, et al. · Thorax · 84

Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease

2014 · Javier Milara, Javier Lluch, et al. · Journal of Allergy and Clinical Immunology · 84

Works count: 418

Citation count: 8,792

H-index: 51

I10-index: 182